Dark

HRTX
Heron Therapeutics, Inc.
stock NASDAQ

At Close

Jan 30, 2026 3:59:59 PM EST

1.33USD-0.746%(-0.01)691,444

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jan 29, 2026 9:15:30 AM EST

1.31USD-2.239%(-0.03)0

After-hours

Jan 29, 2026 4:00:30 PM EST

1.34USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

242.96M

CEO

Barry Quart

Headquarters

San Diego, California, USA

Industry

Biotechnology

Next Earnings

Feb 26, 2026 (25d)

Last Split

May 25, 20071for4reverse

SRDX DRRX NKTR ACHN LGND PCRX ALKS INSY XLV

HRTX Stats

Avg. Vol. 10 Day

978,445

Avg. Vol. 30 Day

1,647,521

Employees

145

Market Cap

242,955,342

Shares Out.

183,362,522

On/Off Exchange

52%/48%

6 Month Beta

1.49

1 Year Beta

0.88

2 Year Beta

1.17

3 Year Beta

1.34

52 Week Low

1.00

52 Week High

2.68

SMA50

1.31

SMA200

1.57

1 Week

-6.69%

1 Month

+1.92%

3 Month

+14.22%

6 Month

-23.41%

1 Year

-22.06%

2 Year

-45.02%

5 Year

-92.77%

Profile

heron therapeutics, inc. (formerly a.p. pharma, inc.) is a specialty pharmaceutical company developing products using its proprietary biochronomer™ polymer-based drug delivery platform. this drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.

HRTX Stock Summary

Heron Therapeutics, Inc. (NASDAQ:HRTX) stock price today is $1.33, and today's volume is 691,444. HRTX is down -0.746% today. The 30 day average volume is 1,647,521. HRTX market cap is 242.96M with 183,362,522 shares outstanding.

.dark-mode .Bsc6lg{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .Bsc6lg{ color: #333333; background-color: white; border: 2px solid #333333; }HRTXHeron Therapeutics, Inc.stock NASDAQ

HRTX Stock Summary

HRTX
Heron Therapeutics, Inc.
stock NASDAQ